Press Releases: In-Vitro Diagnostics

Select a different year:

Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen

February 7, 2012

Research Triangle Park, N.C., San Diego, Tarrytown, N.Y., February 7, 2012 – Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen — marking a major step for Siemens into this important and fast-growing segment of the in vitro diagnostics (IVD) market. Both partnerships intend to leverage the clinical trial and commercialization options within Siemens’ CLIA laboratory, as well as Siemens’ established IVD clinical and regulatory expertise. More

Siemens Automated Mycophenolic Acid Test on Dimension Systems Now Available in U.S.

February 3, 2012

Tarrytown, NY., February 3, 2012 – The Siemens Healthcare Diagnostics Mycophenolic Acid assay (MPAT) is now available for use on the company’s portfolio of Dimension® Integrated Chemistry Systems in the U.S. With this addition, the company becomes the first laboratory diagnostics solutions provider in the nation to offer the consolidation of four fully automated immunosuppressant drug (ISD) assays on a single integrated chemistry system. The four ISD tests—mycophenolic acid, cyclosporine, tacrolimus and sirolimus—are the most commonly prescribed immunosuppressants used by physicians to prevent organ rejection. Now, they can be run simultaneously with routine chemistry tests on the Dimension systems, enabling more comprehensive care for transplant patients. More

Siemens Adds New VERSANT kPCR HCV Assay to Menu of Diagnostic Solutions for Liver Disease Management

January 6, 2012

Tarrytown, N.Y., January 6, 2012 – The Siemens Healthcare Diagnostics VERSANT® HCV RNA 1.0 Assay is now CE-marked for use on the company’s VERSANT kPCR Molecular System, giving laboratories in Europe and Australia access to a new test to aid in the management of individuals infected with hepatitis C (HCV) who are undergoing antiviral therapy. 1,2 This new, highly sensitive automated viral load assay is an important addition to the company’s portfolio of diagnostic solutions for managing patients with liver disease, which includes routine chemistry tests, hepatitis serology tests, viral load testing and ultrasound systems. More